LDLR and peripheral arterial disease: Interactions were not observed except for PAD outcome when combining lower levels of Lp(a) with LDL-C via LDLR target (HR, 0.71; 95% CI: 0.65, 0.76; Pinteraction = .006) (Fig. 4).